RaySearch Laboratories: Two New RayStation Orders in North America  
7/23/2012 10:16:02 AM

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: RaySearch Laboratories AB (STO:RAYB) has received two new orders for its RayStation® treatment planning system from The Carol and Ray Neag Comprehensive Cancer Center in Storrs, Connecticut and from Christiana Care Helen F. Graham Cancer Center in Newark, Delaware. The Carole and Ray Neag Comprehensive Cancer Center, which is part of the University of Connecticut Health Center, offers a complete range of world-class services, from innovative cancer prevention programs to today’s most sophisticated treatments. The center will use RayStation® for advanced contouring and deformable registration. The system will improve the patient workflow by allowing the physicians to perform and analyze the segmentation. As the department has several advanced treatment technologies, they will also use RayStation® to combine doses from several modalities, and use the system’s extensive toolbox for treatment evaluation to assess the different techniques.